DGAP-News: Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure
Ladenburg, Germany, 30 August 2022 Heidelberg Pharma AG (FSE: HPHA) today successfully completed the capital measure adopted on 12 August 2022 and generates gross issue proceeds of approximately EUR80million by placing all new shares.
- Ladenburg, Germany, 30 August 2022 Heidelberg Pharma AG (FSE: HPHA) today successfully completed the capital measure adopted on 12 August 2022 and generates gross issue proceeds of approximately EUR80million by placing all new shares.
- As part of the capital measure, a total of 12,408,648 new shares at a price of EUR 6.44 each were placed.
- With the subscription of a total of 11,838,652 shares, Huadong Investment now holds 25% of Heidelberg Pharma shares.
- Heidelberg Pharma has thus almost completely utilized the Authorized Capital 2020/I available for the issuance of new shares.